12.5-25mg every 4-6 hours
Common effects can include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose increases
Contraception Alternatives and Recommendations During GLP-1 Treatment Long-acting reversible contraceptives (LARCs) bypass absorption concerns entirely
we have not identified a single replacement review that supersedes both for the pan-agonist context
the participants had reached a normal weight or resolved their weight-related health conditions after being on a weekly GLP-1 therapy, in this case either Ozempic (semaglutide) or Zepbound (tirzepatide)
Results depend on individual health factors, adherence to the prescribed program, and medical evaluation